Global Antiemetics Market Size By Type of Drug, By Application (Chemotherapy-Induced Nausea and Vomiting, Hyperemesis Gravidarum), By Route of Administration, By Geographic Scope And Forecast

Antiemetics Market Size And Forecast

Antiemetics Market size was valued at USD 4.84 Billion in 2024 and is projected to reach USD 8.20 Billion by 2031, growing at a CAGR of 6.8% from 2024 to 2031.

Antiemetics are medications used to prevent nausea and vomiting in conditions like chemotherapy, motion sickness, and post-operative recovery. They target neurotransmitters, improving patient comfort, aiding recovery, and enhancing quality of life.

In terms of applications, antiemetics are widely used across medical settings including hospitals, clinics, and at-home care. They are administered to patients undergoing chemotherapy or radiation therapy to manage treatment-induced nausea and vomiting.

Additionally, antiemetics are prescribed for patients experiencing motion sickness during travel or those recovering from surgeries where anesthesia may cause nausea.

The versatility of antiemetics makes them indispensable in managing nausea and vomiting across a spectrum of medical conditions and scenarios.

Antiemetics are widely used in medical settings for managing nausea and vomiting in patients undergoing chemotherapy or radiation therapy, motion sickness during travel, or recovering from surgeries causing anesthesia-induced nausea. Their versatility makes them indispensable in managing various medical conditions and scenarios.

Global Antiemetics Market Regional Analysis

Here is a more detailed regional analysis of the global antiemetics market:

North America

North America dominating in the global antiemetics market, driven by advanced healthcare infrastructure, high healthcare expenditures, and robust research and development activities.

The region benefits from a strong regulatory framework supporting drug approvals and widespread adoption of antiemetic therapies in various clinical settings.

The prevalence of conditions such as cancer, where chemotherapy-induced nausea and vomiting (CINV) are common, contributes to the high demand for antiemetics.

Major pharmaceutical companies based in North America lead in innovation and product development in the antiemetics sector.

Asia Pacific

Asia Pacific is emerging as a rapidly growing market for antiemetics, fueled by expanding healthcare infrastructure, increasing prevalence of chronic diseases, and rising awareness about treatment options.

Countries such as China, India, and Japan are witnessing significant demand for antiemetic drugs, particularly in oncology and supportive care settings.

The region's large population and improving healthcare access contribute to market growth, along with efforts to enhance regulatory frameworks and ensure drug safety and efficacy.

Additionally, partnerships between global pharmaceutical companies and local healthcare providers are accelerating market expansion in Asia Pacific.

Antiemetics Market, By Type of Drug

• Serotonin Antagonists
• Dopamine Antagonists
• NK1 Receptor Antagonists
• Cannabinoids
• Others

Based on Type of Drug, the Global Antiemetics Market is bifurcated into Serotonin Antagonists, Dopamine Antagonists, NK1 Receptor Antagonists, Cannabinoids, and Others. In the antiemetics market, serotonin antagonists currently dominate as the leading segment. These drugs, such as ondansetron and granisetron, are widely used for preventing nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. Serotonin antagonists work by blocking serotonin receptors in the gastrointestinal tract and the brain, effectively reducing the incidence and severity of nausea and vomiting in patients undergoing cancer treatment and other procedures. NK1 receptor antagonists are rapidly growing as the second-largest segment in the antiemetics market.

Antiemetics Market, By Route of Administration

• Oral
• Intravenous
• Rectal
• Transdermal
• Others

Based on Route of Administration, the Global Antiemetics Market is bifurcated into Oral, Intravenous, Rectal, Transdermal, and Others. In the antiemetics market, oral administration currently dominates as the leading segment. Oral antiemetic medications are widely preferred due to their convenience, ease of administration, and patient compliance. They include tablets, capsules, and liquid formulations that can be easily taken by patients at home or in clinical settings to manage nausea and vomiting associated with chemotherapy, motion sickness, or other conditions. Transdermal administration is rapidly growing as the second-largest segment in the antiemetics market.

Antiemetics Market, By Application

• Chemotherapy
• Postoperative Nausea and Vomiting (PONV)
• Nausea and Vomiting Associated with Gastroenteritis
• Hyperemesis Gravidarum
• Others

Based on Application, the Global Antiemetics Market is bifurcated into Chemotherapy, Postoperative Nausea and Vomiting (PONV), Nausea and Vomiting Associated with Gastroenteritis, Hyperemesis Gravidarum, and Others. In the antiemetics market by application, chemotherapy-induced nausea and vomiting (CINV) dominates as the leading segment. Chemotherapy treatments often cause severe nausea and vomiting in cancer patients, impacting their quality of life and treatment adherence. Antiemetic medications, particularly serotonin antagonists and NK1 receptor antagonists, are widely used to prevent and manage CINV, reducing the incidence and severity of symptoms and improving patient comfort during cancer treatment. Postoperative nausea and vomiting (PONV) is rapidly growing as the second-largest segment in the antiemetics market.

Antiemetics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Antiemetics Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the antiemetics market by geography, North America currently dominates as the leading region. This dominance is attributed to advanced healthcare infrastructure, high prevalence of cancer and other conditions requiring antiemetic treatments, and robust research and development activities. North America benefits from a strong regulatory framework that supports the approval and adoption of new antiemetic therapies, ensuring patient access to effective treatments across various healthcare settings. Asia Pacific is rapidly growing as the second-largest region in the antiemetics market.

Key Players

The "Global Antiemetics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Pfizer, Inc., Johnson & Johnson Services, Inc., Hikma Pharmaceuticals Plc., Novartis AG, Torrent Pharmaceuticals Ltd., GlaxoSmithKline Plc., Merck & Co, Inc., Sanofi, Cipla Limited, Baxter, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Mylan, F. Hoffmann-La Roche Ltd., and AstraZeneca plc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.